TheraRadar
Clinical-Stage Companies / Menarini Group

Menarini Group

Pre-Approval PRO BETA
🟡

Slowing Activity

No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 2/18/2025

26
Total Trials
7
Phase 3
13
Phase 2
1
Recruiting
233
Score

Pipeline by Phase

Phase 3
7
Phase 2
13
Phase 1
8

Therapeutic Focus

Acute Pain Irritable Bowel Syndrome With Diarrhea Infantile Colic Tumor Lysis Syndrome Gram Negative Infections

Clinical Trials (26)

NCT04042077 Phase 3 TERMINATED

Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections

Started: 9/25/2019

NCT02120027 Phase 3 TERMINATED

52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)

Started: 2/1/2014

NCT02107196 Phase 3 COMPLETED

12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)

Started: 3/1/2014

NCT02320318 Phase 3 WITHDRAWN

12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)

Started: 10/1/2015

NCT01904149 Phase 3 COMPLETED

Oral Treatment for Gynaecological Post-operative Pain With Dexketoprofen Trometamol and Tramadol Hydrochloride

Started: 5/1/2013

NCT01902134 Phase 3 COMPLETED

Oral Treatment for Orthopaedic Post-operative Pain With Dexketoprofen Trometamol and Tramadol Hydrochloride

Started: 4/1/2013

NCT01724528 Phase 3 COMPLETED

Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies

Started: 10/1/2012

NCT06828848 Phase 2 RECRUITING

A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infections

Started: 2/18/2025

NCT01532518 Phase 2 COMPLETED

Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance

Started: 8/1/2011

NCT02205814 Phase 2 COMPLETED

Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee

Started: 4/1/2014

NCT01303224 Phase 2 COMPLETED

Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)

Started: 10/1/2010

NCT01258153 Phase 2 COMPLETED

Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic

Started: 11/1/2010

NCT01534962 Phase 2 COMPLETED

Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion

Started: 1/1/2012

NCT01307020 Phase 2 COMPLETED

Analgesic Effect of Different Combinations of Dexketoprofen Trometamol With Tramadol Hydrochloride in a Model of Moderate to Severe Pain

Started: 2/1/2011

NCT01091116 Phase 2 COMPLETED

A Locally Injected Bradykinin Antagonist for TReatment of OSteoarthritiS

Started: 3/1/2010

NCT01309009 Phase 2 WITHDRAWN

Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional Treatment

Started: 2/1/2011

NCT00761007 Phase 2 COMPLETED

Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)

Started: 7/1/2008

NCT03767335 Phase 1 COMPLETED

MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer

Started: 11/13/2018

NCT04495621 Phase 1 COMPLETED

MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)

Started: 7/20/2020

NCT03008187 Phase 1 COMPLETED

MEN1703 (SEL24) in Participants With Acute Myeloid Leukemia

Started: 3/10/2017

NCT02353143 Phase 1 TERMINATED

Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid Leukemia

Started: 12/1/2014

NCT03403725 Phase 1 TERMINATED

MEN1309 I.v. Infusion in Pts With CD205-positive Metastatic Solid Tumors and Relapsed or Refractory NHL Ph I Study

Started: 8/28/2017

NCT03605212 Phase 1 TERMINATED

Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults

Started: 2/27/2017

NCT02209454 Phase 1 COMPLETED

Comparative Bioavailability of Dexketoprofen Trometamol Oral Solution vs Tablet Formulations

Started: 4/1/2014

NCT00655083 Phase 1 COMPLETED

A Phase I Study to Evaluate the Oral Absorption of Nepadutant in Infants

Started: 3/1/2008

NCT02777970 Phase 4 COMPLETED

Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar

Started: 4/1/2016

Drug Candidates

Meropenem plus vaborbactam MEN1611 Trastuzumab Fulvestrant Cetuximab MEN1703 MEN1112 Nepadutant Delafloxacin Vancomycin
Activity Status: Slowing
Last Trial Started: 2/18/2025
Last Trial Ended: 2/27/2024
Trials (12 months): 0
Completed Trials: 18
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.